Long Non-coding RNA: Insight Into Mechanisms of Alzheimer's Disease

FRONTIERS IN MOLECULAR NEUROSCIENCE(2022)

Cited 7|Views12
No score
Abstract
Alzheimer's disease (AD), a heterogeneous neurodegenerative disorder, is the most common cause of dementia accounting for an estimated 60-80% of cases. The pathogenesis of AD remains unclear, and no curative treatment is available so far. Increasing evidence has revealed a vital role of non-coding RNAs (ncRNAs), especially long non-coding RNAs (lncRNAs), in AD. LncRNAs contribute to the pathogenesis of AD via modulating amyloid production, Tau hyperphosphorylation, mitochondrial dysfunction, oxidative stress, synaptic impairment and neuroinflammation. This review describes the biological functions and mechanisms of lncRNAs in AD, indicating that lncRNAs may provide potential therapeutic targets for the diagnosis and treatment of AD.
More
Translated text
Key words
long non-coding RNA, Alzheimer's disease, amyloid beta, tau phosphorylation, mitochondrial dysfunction, oxidative stress, synaptic dynamics, biomarker
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined